RecallDepth
Class II Terminated

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
April 1, 2020
Posted
April 8, 2020
Recall Number
D-1079-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25,944 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.

Distribution

U.S.A. Nationwide

Lot / Code Info

Lot #: Q900580, Exp 9/2021

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls